CTSL and COVID-19: We investigated the inhibitory properties of the synthesised complexes towards two enzymes involved in the development of COVID-19, namely cathepsin L and SARS-CoV-2 PLPro (Figure 2, Supplementary Figures 21 and 22, Supplementary Table 4).